FDA Expands Use of MS Drug to Include Children
MONDAY, May 14, 2018 -- The U.S. Food and Drug Administration has expanded its approval of the multiple sclerosis drug Gilenya (fingolimod) to include children aged 10 and older.
It ' s the first multiple sclerosis drug approved for children, the...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Children | Food and Drug Administration (FDA) | Gilenya | Multiple Sclerosis | Pharmaceuticals